Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nitro Games signs amendment with Wargaming

The parties have agreed on a project scope increase with an amendment to the agreement signed in May 2017, resulting in approximately 0.4 MEUR increased revenue for Nitro Games.Nitro Games has signed an amendment to the game development agreement with Wargaming. The parties originally signed a mobile game production agreement in May and with this amendment the parties are amending the terms of this original agreement. Wargaming requested additional features to be introduced into the product, so the parties have agreed to increase the development budget and change the schedule and payment

Electrolux acquires Continental brand in Latin America

Electrolux today announced that the Brazilian court administering the bankruptcy of Mabe Brazil has accepted a BRL 70 million (SEK 178 million) bid to acquire the intellectual property assets of the estate. Electrolux will consequently take over the rights to the Continental brand of home appliances.Continental is a well-known, traditional brand, with a long history of supplying cooking, cooling and laundry products to Brazilian families. “Continental will be a valuable asset to Electrolux, supporting the continued profitable growth in our region,” said Ricardo Cons, Head of Electrolux

Wilson Therapeutics reaches agreement with the FDA and EMA to initiate pivotal Phase 3 FOCuS study with WTX101 in Wilson Disease

Wilson Therapeutics (publ) today announced that the discussions with the U.S Food and Drug Administration (FDA) and the European Medicines Agency (EMA), regarding the study protocol for the single pivotal Phase 3 FOCuS trial for WTX101 in Wilson Disease, have been concluded successfully. Wilson Therapeutics will now complete the preparatory work to start the trial and expects to enroll the first patient in early 2018. WTX101 (bis-choline tetrathiomolybdate) is a first-in-class copper-protein-binding agent with a unique mechanism of action, under investigation as a novel therapy for Wilson

Continued strong sales, although production disturbances in Sweden affect earnings

Inwido’s President and CEO, Håkan Jeppsson, comments the first nine months of 2017:“Inwido’s strong sales trend Inwido continues. In the third quarter, sales rose by 8 percent, and in the first nine months by 16 percent to approximately SEK 4.6 billion (SEK 4,597 million). Order bookings were in line with the third quarter of 2016 and the order backlog was 7 percent higher than at the same point last year.”  “Operating profit amounted to SEK 172 million (202), entailing an operating margin of 11.0 percent (14.0) for the quarter and 9.7 percent (11.3) for the first nine months.”  “

Interim report January-September 2017

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation and the Swedish Securities Market Act. The information was submitted by the below contact persons for publication on 23 October 2017 at 7:45 a.m. CET. Sales remain strong - production disruption affects earnings Third quarter of 2017 · Net sales rose to SEK 1,559 million (1,446), representing an increase of 8 percent. Organic growth was 4 percent · EBITA amounted to SEK 172 million (212) after items affecting comparability of SEK 0 million (10), and the EBITA

Interim report jan-sep 2017: Wihlborgs continues to accelerate

· Rental income rose 11 percent to SEK 1,665 million (1,505). · The operating surplus was up 11 percent at SEK 1,256 million (1,134). · Income from property management improved 13 percent to SEK 863 million (767). · Profit for the period totalled SEK 1,495 million (1,670), corresponding to earnings per share of SEK 19.45 (21.73).“To sum up, we have completed an eventful and successful third quarter, in which we once again posted record figures for both income and earnings. At SEK 333 million, for the first time, income from property management for a single quarter exceeded SEK 300

TOMRA Q3: Preparing for Introduction of Deposit in NSW and All-Time High Sorting Order Intake

Revenues in the third of quarter 2017 amounted to 1,855 MNOK compared to 1,715 MNOK in the third of quarter 2016. This represents an increase of 8%. Adjusted for acquisitions, revenues were unchanged for TOMRA Group. The gross contribution margin was 43% in the quarter, unchanged from the third quarter of 2016. Somewhat improved margins in TOMRA Collection Solutions offset slightly lower margins in TOMRA Sorting Solutions.   The Group reported operating expenses of 496 MNOK in the third quarter, up from 408 MNOK in the third quarter of last year.  This represents an increase of 4%

A step closer to a cure for adult-onset diabetes

In healthy people, exosomes – tiny structures secreted by cells to allow intercellular communication – prevent clumping of the protein that leads to type 2 diabetes. Exosomes in patients with the disease don’t have the same ability. This discovery by a research collaboration between Chalmers University of Technology and Astrazeneca takes us a step closer to a cure for type 2 diabetes.Proteins are the body’s workhorses, carrying out all the tasks in our cells. A protein is a long chain of amino acids that must be folded into a specific three-dimensional structure to work. Sometimes,

QT GROUP PLC'S ANNUAL GENERAL MEETING AND FINANCIAL REPORTS OF PUBLICATION DATES in 2018

Qt Group Plc Stock Exchange Release October 23, 2017Qt Group Plc will publish its 2017 financial statements on February 16, 2018 at 8:00 am. The financial statements will be published as part of the company's annual report, which contains the report of the Board of Directors, consolidated and parent company financial statements, and the auditor's report for the period January 1, – December 31, 2017. At the same time the Corporate Governance Statement and the remuneration report for the financial year 2017 will be published. Qt Group Plc will publish financial reports in 2018 as

QT GROUP PLC INTERIM STATEMENT 1 JANUARY 2017–30 SEPTEMBER 2017

Third quarter: Net sales increased by 16.8 per cent   July–September 2017: · Net sales increased by 16.8 per cent year-on-year to EUR 8,718 thousand (7,467)*. At comparable exchange rates, net sales increased by 19.8 per cent. · The operating result was EUR -1,302 thousand (-899). · The operating margin (EBIT %) was -14.9 per cent (-12.0%). · Earnings per share were EUR -0.05 (-0.04). January–September 2017: · Net sales increased by 11.0 per cent to EUR 26,152 thousand (23,550) At comparable exchange rates, net sales increased by 10.9 per cent. · The operating

Multiconsult ASA – Repurchase of own shares

On 20 October 2017, Multiconsult ASA ("Multiconsult") purchased 2 728 of its own shares at an average price of NOK 87.00 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 89 109 of its own shares.   For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

Nordic Nanovector: Presentations at European Association of Nuclear Medicine annual meeting (EANM)

Oslo, Norway, 23 October 2017 Nordic Nanovector ASA (OSE: NANO) announces the following presentations by the company’s research collaborators at the European Association of Nuclear Medicine annual meeting (EANM; 21-25 October; Vienna, Austria). Abstract:  OP-012 Title:  Pre-dosing with lilotomab prior to antibody-radionuclide conjugate therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumour to red marrow absorbed dose in non-Hodgkin lymphoma patients Authors:  J. Blakkisrud et al. Abstract:  OP-054 Title: Involvement of cell cycle checkpoints in

KONE to equip Melbourne's premium grade office building in Australia with UltraRope

KONE Corporation, press release, October 23,  2017KONE, a global leader in the elevator and escalator industry, has won an order to supply 21 elevators and 4 escalators to the Olderfleet development on 477 Collins Street in Melbourne, Australia. Situated in the heart of Melbourne's CBD and integrated with the Olderfleet's iconic façade, the project will house the city's newest premium grade office building designed with a best-in-class, technology-enabled future workplace in mind.With 58,444sqm of office space spanning 38 levels, the building will be 158 metres in height.

Securitas AB Interim Report January–September 2017

JULY–SEPTEMBER 2017 • Total sales MSEK 22 651 (22 316) • Organic sales growth 5 percent (7) • Operating income before amortization MSEK 1 230 (1 230) • Operating margin 5.4 percent (5.5) • Earnings per share SEK 2.14 (2.00) JANUARY–SEPTEMBER 2017 • Total sales MSEK 68 173 (64 447) • Organic sales growth 4 percent (8) • Operating income before amortization MSEK 3 413 (3 313) • Operating margin 5.0 percent (5.1) • Earnings per share SEK 5.73 (5.32) • Free cash flow/net debt 0.12 (0.12)COMMENTS FROM THE PRESIDENT AND CEO Organic sales growth strengthened

Securitas AB changes publishing date of Interim Report to Sunday, October 22, 2017

NEW DATE AND TIME: Securitas AB will publish the Interim Report for January-September 2017 on Sunday, October 22, at app. 8.00 p.m. (CET).Late Friday evening, personal property was stolen from one of Securitas' managers, including some working materials related to Securitas' financial reporting of the third quarter 2017. As a consequence, Securitas has decided to disclose the Interim Report for January-September 2017 earlier than previously announced. Sunday October 22, at app. 8.00 p.m. (CET) Report release The report will be sent as a press release from Cision (www.cision.se) and

MIV-711 phase IIa osteoarthritis study data selected as late breaking abstract at the Annual Meeting of the American College for Rheumatology

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that data from the initial phase IIa study of MIV-711 in patients with moderate knee osteoarthritis have been selected for late-breaking presentation at the 2017 annual meeting of the American College for Rheumatology (ACR), which will take place Nov 3-8 in San Diego, USA . Professor Philip Conaghan, Professor of Musculoskeletal Medicine at the University of Leeds, UK, and lead investigator on the study, will make the presentation. The abstract summarizing the data that will be presented is now available on the ACR annual

Agromino: Major Holding of Voting rights Announcement

Agromino A/S hereby pursuant to Section 29 of the Danish Securities Trading Act announces receipt of the following notification: As of 16 October 2017 CANACCORD GENUITY GROUP INC, through its subsidiary Hargreave Hale Ltd, controls more than 5% of the voting rights in Agromino A/S. CANACCORD GENUITY GROUP INC in controlling the voting rights attached to the shares in Agromino A/S, is acting for the benefit of discretionary clients of Hargreave Hale Ltd, on behalf of whom Hargreave Hale Ltd controls the voting rights. Investor enquiries Mr. Simon Boughton, CEO of Agromino A/S Tel:

Exercise of the over-allotment option in the IPO of Balco

Carnegie Investment Bank AB (publ) (“Carnegie”) has today notified Balco Group AB (“Balco” or the “Company”) and Segulah IV, L.P. (the “Selling Shareholder”) that the over-allotment option has been exercised in full in respect of 1,928,589 existing shares in Balco and that the stabilisation period has ended.THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD REQUIRE FURTHER REGISTRATION

Exercise of employee share options in Atea ASA ("the Company")

1. Employees in the Atea Group have exercised 960,264 options.Following the share option exercise the Board of Directors, pursuant to authorisation granted by the Company's Annual General Meeting, has decided to increase the Company's share capital by NOK 960,264 by issuing 960,264 new shares, of par value NOK 1. Following the increase, the Company's share capital is NOK 107,581,945 divided into 107,581,945 shares. The weighted average option exercise price is NOK 52,28. 2. Options exercised by primary insiders 20 October 2017:Anders Brix has exercised 15,000 options in the

Minesto News Update 20 October 2017

· Minesto delivers Welsh updates · Minesto speakers at Ocean Energy Europe 2017 · New Cost of Energy analysis reveals substantial improvement · UK Government boosts renewables with £557M funding · Minesto awards IT and communication system to ITS Technology Group · Technical analysis of the Minesto share in Trading DirektMinesto delivers Welsh updates Earlier this week, Minesto’s CEO Dr Martin Edlund had the honour to update members of the National Assembly for Wales. “It is clear that marine energy is a prioritised area of growth for Wales”, said Martin Edlund. Read more

Gjensidige Bank ASA: New senior unsecured SEK bond and buy-back in GJEB17 PRO

Gjensidige Bank ASA today issued SEK 200 million in a new senior bond. The bond has floating interest rate and maturity date 27 October 2022. Gjensidige Bank ASA has at the same time repurchased nominal NOK 230 million in GJEB17 PRO, ISIN NO0010679301 from the market. Facilitator was DNB Markets. This information is subject to disclosure under Oslo Stock Exchange's ABM rules. Contact persons, Gjensidige Bank ASA:Head of Treasury: Tor Egil Nedrebø, Tel: +47 406 25 367Head of Investor Relations: Janne Flessum, Tel: +47 915 14 739 Gjensidige Bank ASA is a wholly owned

Romantic Cities: The time before Christmas is the time for presents

Koblenz/Weinheim, 2017 – Let’s be honest: all of us can get stressed while we are looking for the right gift for our loved ones. The Romantic Cities offer two solutions for this. Apart from the fact that the Christmas markets  offer the perfect occasion to escape the turmoil and maybe even find a suitable gift – like a Jürgen Klopp Luther Bible – the cities themselves may just have one or two surprises for their guests. Since September, Idar-Oberstein is the starting point for the new Hildegard von

PostNord’s owners agree on solution for transformation in Denmark

PostNord’s owners, the Swedish and Danish states, have today signed an agreement that will involve the owners providing funding of SEK 2.2 billion for the transformation of the Danish operations.The agreement will result in SEK 1,533m being provided by the Danish state, which constitutes a payment for ensuring the universal postal service, and is earmarked specifically to cover extra legacy costs relating to the reduction of Danish employees with special employment conditions. SEK 267m constitutes an equity contribution from the Danish state and SEK 400m constitutes an equity contribution

Read original

#17-986 Listing of Mini futures issued by SG Issuer

As from October 23, 2017, 47 Mini futures issued by SG Issuer will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: SG Issuer Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from October 23, 2017 and forward or until time for knock out event Market Maker: Societe Generale Underlying: DAX 30 Index Dow Jones Industrial Average EURO STOXX 50 Index Nasdaq 100 S&P 500 Index OMXS30 index Current values of strike and barrier can be

There are no items matching the current filter
There are no more items matching the current filter
Back to top